loader image
Friday, December 19, 2025
55.7 F
McAllen
- Advertisement -

Danish Studies Find Higher Risk of Optic Nerve Damage with Ozempic

Translate to Spanish or other 102 languages!

Image source: https://creativecommons.org/licenses/by-sa/4.0/  Bgd for illustration purposes
Image source: https://creativecommons.org/licenses/by-sa/4.0/ Bgd for illustration purposes
- Advertisement -

Two large studies from the University of Southern Denmark suggest that the diabetes medication Ozempic doubles the risk of developing NAION, a rare but serious condition that damages the optic nerve.

Drawing on comprehensive data from Danish and Norwegian health registers, the studies validate earlier concerns raised in a smaller American study.

While the absolute risk remains low, researchers suggest the findings should guide discussions between doctors and patients about the benefits and risks of treatment with Ozempic.

- Advertisement -

Two research teams conducted separate studies using different methods to analyze all Danish users of Ozempic.

Follow the link below to read the full story om Medical News Today:

https://www.medicalnewstoday.com/articles/danish-studies-find-higher-risk-optic-nerve-damage-diabetes-drug-ozempic?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-01-03&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 

DHR Health Awarded Large Employer of the Year by Texas Workforce Commission

Workforce Solutions Lower Rio Grande Valley (WFS) proudly announced that its nominee, DHR Health, has been awarded the Large Employer of the Year Award at the 28th Annual Texas Workforce Commission (TWC) Conference.
- Advertisement -
×